BIOCARDIA INC(NASDAQ:BCDA) stock News

BCDA Latest News, Press Relases and Analysis

All

Press Releases

14 days ago - By: BioCardia, Inc.

BioCardia Regains Compliance with Nasdaq Listing Requirements

a month ago - By: Benzinga - Mentions: PBM SLRX REPL CURX ...

12 Health Care Stocks Moving In Thursday's Intraday Session

a month ago - By: Benzinga - Mentions: INTC LWAY DRI REPL ...

Gold Falls Over 1%; Darden Posts Downbeat Earnings

a month ago - By: BioCardia, Inc.

BioCardia Announces Pricing of Up To $12 Million Public Offering

a month ago - By: BioCardia, Inc.

BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Top Line Data of Roll-in Cohort Show Improved Exercise Tolerance and Reduced Angina Episodes at Six-Month Primary Follow-up

a month ago - By: BioCardia, Inc.

BioCardia CEO Peter Altman to Present at the H. C. Wainwright 27th Annual Global Investment Conference in New York City September 8-10, 2025

2 months ago - By: The Motley Fool

BioCardia Narrows Loss in Fiscal Q2

2 months ago - By: BioCardia, Inc.

BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results

2 months ago - By: BioCardia, Inc.

BioCardia to Host Q2 2025 Corporate Update and Financial Results Conference Call on August 11, 2025

2 months ago - By: BioCardia, Inc.

BioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP® Cell Therapy for Heart Failure and Helix™ Transendocardial Delivery Catheter

3 months ago - By: BioCardia, Inc.

BioCardia Submits Request for Clinical Data Review Meeting with Japan PMDA To Discuss Approval Pathway for CardiAMP® Cell Therapy in Ischemic Heart Failure

3 months ago - By: BioCardia, Inc.

Henry Ford Health Initiates Patient Enrollment for BioCardia’s CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction

5 months ago - By: BioCardia, Inc.

BioCardia to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21, 2025

5 months ago - By: BioCardia, Inc.

BioCardia Reports First Quarter 2025 Business Highlights and Financial Results

5 months ago - By: BioCardia, Inc.

BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025

6 months ago - By: BioCardia, Inc.

BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company’s Lead Cell Therapy for Treatment of Heart Failure

6 months ago - By: Yahoo Finance - Mentions: AZN NFLX TSLA SIGA ...

Is AstraZeneca PLC (AZN) the Best Pharma Stock to Buy for Long Term Growth?

6 months ago - By: BioCardia, Inc.

BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial

6 months ago - By: BioCardia, Inc.

BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study

7 months ago - By: BioCardia, Inc.

BioCardia’s Conference Call Today, Monday, March 31, 2025 to be Held at 4:30PM EDT Time Today

7 months ago - By: BioCardia, Inc.

BioCardia Reports 2024 Business Highlights and Financial Results

7 months ago - By: BioCardia, Inc.

BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025

7 months ago - By: BioCardia, Inc.

BioCardia Announces Japanese Patent for Helix™ Biotherapeutic Delivery System

8 months ago - By: BioCardia, Inc.

BioCardia Announces Primary Outcome Measures Data Freeze in CardiAMP Heart Failure Trial for Presentation at the American College of Cardiology 2025 Scientific Sessions

8 months ago - By: BioCardia, Inc.

BioCardia Reports Completion of Low Dose Cohort Enrollment for CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells to Treat Ischemic Heart Failure of Reduced Ejection Fraction (HFrEF)

9 months ago - By: BioCardia, Inc.

BioCardia Announces Late Breaking Clinical Trial Presentation on CardiAMP Heart Failure Trial at the American College of Cardiology 2025 Scientific Sessions

BIOCARDIA INC (BCDA) Stock News

BCDA Latest News, Press Relases and Analysis